23-999-114
Chembio Diagnostic Systems, Inc. DPP HIV-Syphilis Control Pack
Manufacturer: Chembio Diagnostic Systems, Inc.
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Pack of 1 | 23-999-114-Pack-of-1 | In Stock | ₹ 9,523.00 |
23-999-114 - Pack of 1
In Stock
Quantity
1
Base Price: ₹ 9,523.00
GST (18%): ₹ 1,714.14
Total Price: ₹ 11,237.14
Certifications/Compliance
Moderately Complex
Control Sets
One HIV-1 / Syphilis Reactive Control, One HIV-2 Reactive Control, One Non-reactive Control
Clia Complexity
Moderate
Sample Type
Fingerstick whole blood, venous whole blood, or plasma
For Use With (Application)
Assay Controls
Packaging Type
1 kit (contains 3 vials)
Content And Storage
2°C to 8°C
CE Marker
Yes
Detectable Analytes
HIV, T. pallidum
Type
Assay Controls
Material
Polypropylene Vials
Quantity
1 Set of Controls
Related Products
Description
- Chembio's DPP HIV-Syphilis Reactive/Nonreactive Controls are quality control reagents for use with DPP HIV-Syphilis
- Each DPP HIV-Syphilis Rapid Test Control Pack contains a Product Insert and three 3 Vials One HIV-1 / Syphilis Reactive Control One HIV-2 Reactive Control One Non-reactive Control
SAFETY INFORMATION
- ShelfLife : 24 Months from DOM
Compare Similar Items
Show Difference
Certifications/Compliance: Moderately Complex
Control Sets: One HIV-1 / Syphilis Reactive Control, One HIV-2 Reactive Control, One Non-reactive Control
Clia Complexity: Moderate
Sample Type: Fingerstick whole blood, venous whole blood, or plasma
For Use With (Application): Assay Controls
Packaging Type: 1 kit (contains 3 vials)
Content And Storage: 2°C to 8°C
CE Marker: Yes
Detectable Analytes: HIV, T. pallidum
Type: Assay Controls
Material: Polypropylene Vials
Quantity: 1 Set of Controls
Certifications/Compliance:
Moderately Complex
Control Sets:
One HIV-1 / Syphilis Reactive Control, One HIV-2 Reactive Control, One Non-reactive Control
Clia Complexity:
Moderate
Sample Type:
Fingerstick whole blood, venous whole blood, or plasma
For Use With (Application):
Assay Controls
Packaging Type:
1 kit (contains 3 vials)
Content And Storage:
2°C to 8°C
CE Marker:
Yes
Detectable Analytes:
HIV, T. pallidum
Type:
Assay Controls
Material:
Polypropylene Vials
Quantity:
1 Set of Controls
Certifications/Compliance: __
Control Sets: __
Clia Complexity: __
Sample Type: __
For Use With (Application): __
Packaging Type: __
Content And Storage: __
CE Marker: __
Detectable Analytes: __
Type: __
Material: __
Quantity: __
Certifications/Compliance:
__
Control Sets:
__
Clia Complexity:
__
Sample Type:
__
For Use With (Application):
__
Packaging Type:
__
Content And Storage:
__
CE Marker:
__
Detectable Analytes:
__
Type:
__
Material:
__
Quantity:
__
Certifications/Compliance: __
Control Sets: __
Clia Complexity: Waived
Sample Type: Direct Nasal Swab
For Use With (Application): Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Packaging Type: __
Content And Storage: 15°C to 30°C
CE Marker: Yes
Detectable Analytes: SARS-CoV-2 Antigens
Type: SARS-CoV-2 Rapid Antigen Test
Material: __
Quantity: 50 Tests/Kit
Certifications/Compliance:
__
Control Sets:
__
Clia Complexity:
Waived
Sample Type:
Direct Nasal Swab
For Use With (Application):
Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Packaging Type:
__
Content And Storage:
15°C to 30°C
CE Marker:
Yes
Detectable Analytes:
SARS-CoV-2 Antigens
Type:
SARS-CoV-2 Rapid Antigen Test
Material:
__
Quantity:
50 Tests/Kit
Certifications/Compliance: __
Control Sets: __
Clia Complexity: Waived
Sample Type: Direct Nasal Swab
For Use With (Application): Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Packaging Type: __
Content And Storage: 15°C to 30°C
CE Marker: Yes
Detectable Analytes: SARS-CoV-2 Antigens
Type: SARS-CoV-2 Rapid Antigen Test
Material: __
Quantity: 20 Tests/Kit
Certifications/Compliance:
__
Control Sets:
__
Clia Complexity:
Waived
Sample Type:
Direct Nasal Swab
For Use With (Application):
Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Packaging Type:
__
Content And Storage:
15°C to 30°C
CE Marker:
Yes
Detectable Analytes:
SARS-CoV-2 Antigens
Type:
SARS-CoV-2 Rapid Antigen Test
Material:
__
Quantity:
20 Tests/Kit